COMMERCIALRADIOPHARMACYNETWORK
Jubilant Pharma is a Partner of Choice for R&D, manufacture and supply ofGenerics - Dosage Formulations and APIs, Specialty Pharmaceuticals –
Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of
Sterile Injectables. We have Business partnerships in over 65 countries.
Corporate Office: 1A, Sector 16A, Noida - 201301, U.P., INDIA
Tel: +91 120 4361000 Fax: +91 120 2516628
Tel.: 1-888-633-5343 or 514-630-7080 Fax: 1-866-431-4288 or 514-694-3865
You can also write to us for business specific inquiries at: [email protected]
To know more log on to: www.jubilantpharma.com
ubilant Life Sciences, through its subsidiary, Jubilant
JPharma, operates a Commercial Radiopharmacy Network, Jubilant DraxImage Radiopharmacies. With more than 30 years of experience in preparing
radioisotopes, Jubilant DraxImage Radiopharmacies, is a
nuclear pharmacy network with a team of highly skilled
nuclear pharmacists delivering the specialized expertise
and customized solutions critical to supporting and
enhancing the nuclear medicine industry.
Headquartered in Orlando, Florida, Jubilant DraxImage
Radiopharmacies operates a nationwide network of nuclear
pharmacies in the USA. Fifty-one (51) locations provide
single photon emission computed tomography (SPECT)
prescriptions and three have on-site cyclotrons that provide
positron emission tomography (PET) products. Together,
those locations serve 4 million patients each year, making
Jubilant DraxImage Radiopharmacies the second-largest
nuclear pharmacy company in the United States.
Jubilant DraxImage Radiopharmacies offers a wide
spectrum of Nuclear Medicine products that provide safe
and cost-effective ways to image the body and treat
disease. The pharmacies are “open formulary”, providing
customers with a full array of radiopharmaceutical options.
This allows clinicians to select the products they prefer to
achieve the highest benefit for their patients. Multi-source
arrangements for key products — such as Tc99m
Generators, Sestamibi, Technetium and Thallium — help
ensure supply availability.
In accordance with State Board of Pharmacy regulations,
prescription orders are required for all radiopharmaceutical
products dispensed by Jubilant DraxImage
Radiopharmacies. Prior to delivery, a specially trained team
member performs radiopharmaceutical quality assurance
testing (QC) on every compounded preparation before it
leaves the pharmacy.
Jubilant DraxImage Radiopharmacies procures and
supplies only FDA-approved sterile injectable
radiopharmaceutical products and fully supports USP
compounding standards during compounding and
dispensing.
Jubilant DraxImage Radiopharmacies’ Institute of Learning
is dedicated to advancing the field of Nuclear Medicine
through education, research, publishing and identification
of innovative best practices. The Institute draws from the
thought leadership of Jubilant DraxImage
Radiopharmacies, including clinicians, technologists,
nuclear pharmacists and other professionals, who together
bring decades of experience in SPECT, PET imaging,
including the regulatory expertise as part of the Jubilant
DraxImage Radiopharmacies team. Through the Institute,
the team of subject matter experts are available to consult
on clinical and technical issues related to nuclear agents
and provide guidance on regulatory mandates.
On-Going “Live” CE (Continuing Education) courses are
presented by the Institute's fully certified Strategic
Teaching and Training (S.T.A.T.) Team comprised of nuclear
pharmacists, technicians, and quality and safety
professionals, as well as certified representatives of our
industry partners. Many CE courses are also available as
free, on-demand courses through our Online Learning
Center.
Jubilant DraxImage Radiopharmacies, Inc. is currently
doing business as Triad Isotopes.
For More Information:www.triadisotopes.com